MedPath

Bausch & Lomb Incorporated

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
1992-10-08
Employees
-
Market Cap
-
Website

Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome

Phase 2
Completed
Conditions
Dry Eye Syndromes
Interventions
First Posted Date
2005-09-20
Last Posted Date
2013-03-14
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
159
Registration Number
NCT00198536
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Eyesight Ophthalmic Services, PA, Dover, New Hampshire, United States

๐Ÿ‡บ๐Ÿ‡ธ

Central Maine Eye Care, Lewiston, Maine, United States

๐Ÿ‡บ๐Ÿ‡ธ

Andover Eye Associates, Andover, Massachusetts, United States

Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)

Phase 1
Completed
Conditions
Drug Hypersensitivity
Interventions
First Posted Date
2005-09-20
Last Posted Date
2013-03-14
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
65
Registration Number
NCT00198419
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Solano Clinical Research (A Division of Dow Pharmaceutical Sciences), Davis, California, United States

Evaluation of Vitrase as a Spreading Agent

Phase 3
Completed
Conditions
Pain
Interventions
First Posted Date
2005-09-20
Last Posted Date
2013-03-14
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
108
Registration Number
NCT00198484
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Donald E Beahm, MD, Great Bend, Kansas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Ophthalmic Consultants of Long Island, Rockville Centre, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Cornea Consultants, Boston, Massachusetts, United States

and more 15 locations

A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte

Phase 3
Completed
Conditions
Eye Infections
Postoperative Complications
Interventions
First Posted Date
2005-09-20
Last Posted Date
2013-03-15
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
132
Registration Number
NCT00198523
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Cornea Consultants/Laser Eye Consultants of Boston, Boston, Massachusetts, United States

๐Ÿ‡บ๐Ÿ‡ธ

Donald E. Beahm, MD, Great Bend, Kansas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Great Lakes Eye Care, St. Joseph, Michigan, United States

and more 3 locations

Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery

Phase 3
Completed
Conditions
Postoperative Complications
Cataract
Interventions
Drug: Placebo
First Posted Date
2005-09-20
Last Posted Date
2013-03-14
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
527
Registration Number
NCT00198445
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Eye Care of San Diego, San Diego, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Cornea Consultants, Boston, Massachusetts, United States

๐Ÿ‡บ๐Ÿ‡ธ

Ophthalmic Consultants of Long Island, Rockville Centre, New York, United States

and more 36 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath